Literature DB >> 16447252

TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas.

Claudia Augello1, Valter Gregorio, Viviana Bazan, Patrizia Cammareri, Valentina Agnese, Sandra Cascio, Simona Corsale, Valentina Calò, Arianna Gullo, Rita Passantino, Grazia Gargano, Loredana Bruno, Gaetana Rinaldi, Vincenza Morello, Aldo Gerbino, Rosa Maria Tomasino, Marcella Macaluso, Eva Surmacz, Antonio Russo.   

Abstract

The putative role of TP53 and p16(INK4A) tumor suppressor genes and Ras oncogenes in the development and progression of salivary gland neoplasias was studied in 28 cases of pleomorphic adenomas (PA), 4 cases of cystic adenocarcinomas, and 1 case of carcinoma ex-PA. Genetic and epigenetic alterations in the above genes were analyzed by Polymerase Chain Reaction/Single Strand Conformational Polymorphism (PCR/SSCP) and sequencing and by Methylation Specific-PCR (MS-PCR). Mutations in TP53 were found in 14% (4/28) of PAs and in 60% (3/5) of carcinomas. Mutations in H-Ras and K-Ras were identified in 4% (1/28) and 7% (2/28) of PAs, respectively. Only 20% (1/5) of carcinomas screened displayed mutations in K-Ras. p16(INK4A) promoter hypermethylation was found in 14% (4/28) of PAs and 100% (5/5) carcinomas. All genetic and epigenetic alterations were detected exclusively in the epithelial and transitional tumor components, and were absent in the mesenchymal parts. Our analysis suggests that TP53 mutations and p16(INK4A) promoter methylation, but not alterations in the H-Ras and K-Ras genes, might be involved in the malignant progression of PA into carcinoma. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16447252     DOI: 10.1002/jcp.20601

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.

Authors:  Megan L Durr; Wojciech K Mydlarz; Chunbo Shao; Marianna L Zahurak; Alice Y Chuang; Mohammad O Hoque; William H Westra; Nanette J Liegeois; Joseph A Califano; David Sidransky; Patrick K Ha
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

2.  Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.

Authors:  Sarah L Anzick; Wei-Dong Chen; Yoonsoo Park; Paul Meltzer; Diana Bell; Adel K El-Naggar; Frederic J Kaye
Journal:  Genes Chromosomes Cancer       Date:  2010-01       Impact factor: 5.006

3.  HRAS mutations in epithelial-myoepithelial carcinoma.

Authors:  Simion I Chiosea; Megan Miller; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2013-11-26

4.  Assessment of TP53 mutations in benign and malignant salivary gland neoplasms.

Authors:  Carolina Cavaliéri Gomes; Marina Gonçalves Diniz; Lissur Azevedo Orsine; Alessandra Pires Duarte; Thiago Fonseca-Silva; Brendan I Conn; Luiz De Marco; Cláudia Maria Pereira; Ricardo Santiago Gomez
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

5.  Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.

Authors:  A G Schache; G Hall; J A Woolgar; G Nikolaidis; A Triantafyllou; D Lowe; J M Risk; R J Shaw; T Liloglou
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

6.  Genomic landscape of salivary gland tumors.

Authors:  Shumei Kato; Sheryl K Elkin; Maria Schwaederle; Brett N Tomson; Teresa Helsten; Jennifer L Carter; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.